HRT FINANCIAL LP

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1475597 NEW YORK, NY

Position in TAK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,467,657

+$2,132,767 QoQ

Shares Held

278,706

+121.1% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#46

of 376 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $132,018,496 across 28 Drug Manufacturers - Specialty & Generic names. TAK ranks #8 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	98,864	$53,567,481
2	ZTS	Zoetis Inc.	241,369	$17,344,776
3	BCRX	Biocryst Pharmaceuticals Inc	1,081,523	$10,815,230
4	TEVA	Teva Pharmaceutical Industries Ltd	295,918	$10,025,701
5	AMPH	Amphastar Pharmaceuticals, Inc.	387,530	$7,820,355
6	HLN	Haleon plc	682,281	$6,365,681
7	ANIP	Ani Pharmaceuticals Inc	63,008	$5,215,802
8	TAK	Takeda Pharmaceutical Co Ltd This page	278,706	$4,467,657

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,467,657	278,706	+121.1%	Shares	Defined	2026-08-14
2026-03-31	$2,334,890	126,074	+113.4%	Shares	Defined	2026-05-14
2025-12-31	$921,072	59,081	+29.2%	Shares	Defined	2026-02-12
2025-09-30	$669,516	45,732	+12.2%	Shares	Defined	2025-11-14
2025-06-30	$630,350	40,773	+86.1%	Shares	Defined	2025-08-14
2025-03-31	$325,771	21,908	-5.5%	Shares	Defined	2025-05-15
2024-03-31	$322,178	23,195	-61.1%	Shares	Defined	2024-05-13
2023-06-30	$936,740	59,627	+68.2%	Shares	Defined	2023-08-11
2023-03-31	$584,067	35,441	-55.0%	Shares	Defined	2023-05-12
2021-03-31	$1,439,381	78,827	+263.9%	Shares	Defined	2021-05-17
2020-09-30	$386,450	21,662	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.